Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hillerod Hospital, Denmark
With
Medicon Valley Academy
In this study we aimed at investigating to what degree rTMS applied over the left dorsolateral cortex relieves depressive symptoms when the treament is combined with antidepressive medication. The study will also be able to supply knowledge on how long any possible effect of the rTMS treatment lasts.
In the first 12 weeks of the trial participants are randomised to either rTMS combined with escitalopram or sham rTMS combined with escitalopram. rTMS is given daily for the first 3 weeks.
The next phase is a relapse prevention study where the responders from the initial phase are randomised to either active or placebo escitalopram for 24 weeks.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Major depression Hamilton score above 18
Age 18 to 75
You may not be if
Pregnancy og breastfeeding
Mental retardation and organic brain disease
Alcohol and substance abuse
Metal implants in brain, pacemakers and other electronic implants
